JPS52139018A - Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester - Google Patents

Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester

Info

Publication number
JPS52139018A
JPS52139018A JP2552977A JP2552977A JPS52139018A JP S52139018 A JPS52139018 A JP S52139018A JP 2552977 A JP2552977 A JP 2552977A JP 2552977 A JP2552977 A JP 2552977A JP S52139018 A JPS52139018 A JP S52139018A
Authority
JP
Japan
Prior art keywords
ester
adjuvant
nnacetyllmuramiccllalanylldd
nnacetyll
muramiccllalanyllddglutamic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2552977A
Other languages
Japanese (ja)
Other versions
JPS6225679B2 (en
Inventor
Odeibeeru Furansowaazu
Shiedeidou Rui
Rufuranshie Pieeru
Shiyoai Jiyan
Rudoure Edogiyaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7606820A external-priority patent/FR2343483A1/en
Priority claimed from FR7702646A external-priority patent/FR2369292A1/en
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS52139018A publication Critical patent/JPS52139018A/en
Publication of JPS6225679B2 publication Critical patent/JPS6225679B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2552977A 1976-03-10 1977-03-10 Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester Granted JPS52139018A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7606820A FR2343483A1 (en) 1976-03-10 1976-03-10 Immunogical adjuvants for weak vaccine antigens - are (2)-acetamido-deoxy (D)-glucopyranosyl (D)-propionyl (L)-alanyl (D)-glutamic acid esters and (D)-isoglutamines
FR7702646A FR2369292A1 (en) 1976-11-02 1977-01-31 ADJUSTING AGENTS IMMUNITY

Publications (2)

Publication Number Publication Date
JPS52139018A true JPS52139018A (en) 1977-11-19
JPS6225679B2 JPS6225679B2 (en) 1987-06-04

Family

ID=26219340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2552977A Granted JPS52139018A (en) 1976-03-10 1977-03-10 Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester

Country Status (2)

Country Link
JP (1) JPS52139018A (en)
GB (1) GB1573126A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54141718A (en) * 1978-02-24 1979-11-05 Ciba Geigy Ag Novel antigen derivative and its manufacture
JPS55392A (en) * 1978-06-05 1980-01-05 Anvar Muramyllpeptide type novel compounds and drug containing them
JPS55500167A (en) * 1978-03-20 1980-03-27
JPS55102599A (en) * 1979-01-29 1980-08-05 Merck & Co Inc Immunologically active dipertidyl saccharides and manufacture
JPS62265231A (en) * 1986-05-13 1987-11-18 Zenkoku Nogyo Kyodo Kumiai Rengokai Method for preventing infection of diarrhea of piglet after weaning

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54141718A (en) * 1978-02-24 1979-11-05 Ciba Geigy Ag Novel antigen derivative and its manufacture
JPH0130809B2 (en) * 1978-02-24 1989-06-22 Ciba Geigy
JPS55500167A (en) * 1978-03-20 1980-03-27
JPS55392A (en) * 1978-06-05 1980-01-05 Anvar Muramyllpeptide type novel compounds and drug containing them
JPH0233720B2 (en) * 1978-06-05 1990-07-30 Anbaaru Ajansu Nashionaru Do Barorizashion Do Ra Rusherushu
JPS55102599A (en) * 1979-01-29 1980-08-05 Merck & Co Inc Immunologically active dipertidyl saccharides and manufacture
JPS62265231A (en) * 1986-05-13 1987-11-18 Zenkoku Nogyo Kyodo Kumiai Rengokai Method for preventing infection of diarrhea of piglet after weaning

Also Published As

Publication number Publication date
JPS6225679B2 (en) 1987-06-04
GB1573126A (en) 1980-08-13

Similar Documents

Publication Publication Date Title
GB1556781A (en) Copolyester preparation and use thereof
JPS5367071A (en) Buffer and buffer ring thereof
JPS5379844A (en) Cyclopentanee11amine and like * and its preparation
JPS5295790A (en) Preparation of homoo and coopolymer of alphaamonoolefin
AU2949677A (en) Cancer-testing and immunization
JPS5291814A (en) Polyfluoroalkylthioalcohol and ester * their preparation and use
JPS52139191A (en) Copolyester and preparation thereof
GB2038712B (en) Absorbent and/or reflecting shield
JPS52111552A (en) 44androstenee33one and preparation thereof
JPS52105173A (en) Preparation and use of thiadiazolylbenzamides
JPS52139018A (en) Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester
GB1557506A (en) Preparation of esters
TR20919A (en) TUEREVS OF BROMOXINILE AND IYOXINILE ESTERS
JPS5622799A (en) 255halocholesterr55enee3beta*222diol and its ester
JPS52131534A (en) Aralkylarylamine and preparation thereof
JPS52139194A (en) Copolyester and preparation thereof
JPS5291859A (en) 22furanones and preparation thereof
IL52668A (en) 7 -amino-1-oxa-1-dethiacephalosporins and their preparation
JPS56115743A (en) Alpha ester and its manufacture
JPS5346977A (en) 55secondary alkylidenehydantoin and its preparation
JPS52100480A (en) Substituted ppaminophenyllasstriazinedione and its preparation
JPS532401A (en) Antibioticsaa3551 and method of preparation thereof
JPS52156864A (en) Preparation of cholesistquininn pancreozyminoctapeptideamidosulfate ester
PH14030A (en) Derivatives of 2-iminothiazolidine and 2-iminothiazoline
JPS5439086A (en) Ester of carboxyaminophenylisocyanurate and vinylidenecarbonyloxyalkanol